Orphan Indications for CD19 Redirected Autologous T Cells

Clinical trial NCT04276870 · RECRUITING

Trial details

NCT number: NCT04276870
Sponsor: Stephan Grupp MD PhD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL Infants With Very High Risk KMT2A B-ALL Patients With Central Nervous System Relapse Who Did Not Receive Cranial Radiation or Bone Marrow Transplantation

Start date: 2020-03-12
Primary completion: 2028-03-10
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.